240
Participants
Start Date
August 20, 2018
Primary Completion Date
January 1, 2029
Study Completion Date
January 1, 2029
Cisplatin
Given IV
Etoposide
Given IV
Mitotane
Given PO
Quality-of-Life Assessment
Ancillary studies
RECRUITING
CHRU Jean Minjoz, Besançon
RECRUITING
Centre Georges François Leclerc, Dijon
RECRUITING
CHU La Cavale Blanche, Brest
RECRUITING
Hôpital Larrey, Toulouse
RECRUITING
University of Michigan Comprehensive Cancer Center, Ann Arbor
ACTIVE_NOT_RECRUITING
Siteman Cancer Center at Washington University, St Louis
NOT_YET_RECRUITING
Hôpital Cochin, Paris
RECRUITING
Hôpital COCHIN, Paris
RECRUITING
M D Anderson Cancer Center, Houston
RECRUITING
CHU Larrey, Angers
RECRUITING
Institut de Cancérologie de l'Ouest (ICO), Angers
RECRUITING
HCL Louis pradel, Lyon
RECRUITING
CHU René et Guillaume Laënnec, Nantes
RECRUITING
CHU René et Guillaume Laënnec, Nantes
RECRUITING
CHU Bordeaux - Hôpital, Pessac
RECRUITING
CHU Poitiers, Poitiers
RECRUITING
HUS Hautepierre, Strasbourg
RECRUITING
Hôpital Rangueil, Toulouse
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
Sahlgrenska University Hospital, Gothenburg
RECRUITING
Karolinska University Hospital, Stockholm
RECRUITING
Akademiska Sjukhuset, Uppsala
RECRUITING
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice
National Cancer Institute (NCI)
NIH
Assistance Publique - Hôpitaux de Paris
OTHER
University Hospital Wurzburg
UNKNOWN
University Hospital Munich
OTHER
Skanes Universitetssjukhus
UNKNOWN
M.D. Anderson Cancer Center
OTHER